HOME >> BIOLOGY >> NEWS
Antimicrobial resistance poses increasing problem for growers

St. Paul, MN (August 23, 2001) An apple a day may keep the doctor away but apples themselves are often the victims of disease. In the past, growers have used antimicrobial compounds (or antibiotics as theyre more commonly known) to control fire blight, a common bacterial disease plaguing apples. But antimicrobial compounds are becoming less effective as microorganisms develop resistance to them. In fact, antimicrobial resistance is becoming an increasing problem for growers of other crops as well, and on August 29, the worlds largest group of plant health scientists will meet to discuss the problem of antimicrobial resistance in agriculture.

Antimicrobial agents play an important role in the control of plant diseases, both in the field and after harvesting states Paul Lewis, a plant health scientist, and organizer of the symposium planned for the end of August. Adds Lewis, Apples are a good example since antibiotics are critical for controlling fire blight disease and obtaining an acceptable harvest. However, apple and pear growers are really struggling with the effects of antibiotic resistance.

Since antimicrobial resistance has implications not only for the agricultural community, but the clinical and veterinary communities as well, Lewis has invited experts from these scientific disciplines to share their experience. He hopes their knowledge of the subject will provide new insights for plant disease scientists hoping to uncover alternative methods to fight diseases that are now being controlled with antimicrobial compounds. States Lewis, Its critical that we examine methods to prevent and/or manage antimicrobial resistance if we are to continue to receive the substantial benefits these agents offer. This symposium is designed to help us begin to do just that.


'"/>

Contact: Cindy Ash
cash@scisoc.org
651-454-7250
American Phytopathological Society
24-Aug-2001


Page: 1

Related biology news :

1. Antimicrobial peptides: new weapons to fight infection
2. Nabi reports successful reduction in S. aureus bacteremias at Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
3. Antimicrobial Resistance: Issues And Options
4. Enzymes "Magic" May Hold Key to Anticancer and Antimicrobial Drugs
5. Master of antimalarial resistance
6. Anthrax enzyme images reveal secrets of antibiotic resistance, suggest new drug design
7. Evolvability could be a driving force in drug resistance
8. Insecticide resistance: A constraint on evolutionary change
9. New drug shows promise against Gleevec resistance in mice
10. New milestones on the path to conquering HIV drug resistance (AIDS)
11. Study investigates breast cancer resistance to tamoxifen and possible way to reverse it

Post Your Comments:
(Date:3/12/2015)... 12, 2015 IriTech, a leading iris based ... the Texas Instruments Design Network, announced today that the ... its IriShield USB MK2120U device during a launching event ... distribution. The iris scanner is manufactured ... in India through its Indian ...
(Date:3/11/2015)...   The Sync Project™ today announced ... and harness music to improve health. The platform ... measurements of physiology, enabling the study of the ... populations. It is designed for medical and health ... studies and accelerate the discovery of the clinical ...
(Date:3/5/2015)... 5, 2015 In Brazil , ... already using these solutions and 42 percent planning to invest ... approximately 25 percent of the companies will be investing in ... majority of companies in the region are currently opting for ... model will command significant attention in the coming years. This ...
Breaking Biology News(10 mins):Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4
(Date:3/27/2015)... UK (PRWEB) March 27, 2015 The ... the back of the recession and high prices in ... market has recovered and keeps on gaining momentum now. ... NPK stands at more than 100,000 thousand tonnes. No ... years. Meantime, the global capacity rocketed during 2012-2013, registering ...
(Date:3/27/2015)... , March 27, 2015   SurePure, ... liquid photopurification, announced today that the Company has ... the continued trading of SurePure ("SURP") securities on ... marketplace for entrepreneurial and development stage companies. ... introduced standards and eligibility requirements designed to improve ...
(Date:3/27/2015)... March 27, 2015 WuXi PharmaTech (Cayman) ... R&D capability and technology platform company serving the ... today that an Investigational New Drug (IND) application ... rheumatoid arthritis has been accepted for review by ... In September 2012, MedImmune, the global ...
(Date:3/26/2015)... 2015  Roka Bioscience, Inc. (NASDAQ: ROKA ... advanced testing solutions for the detection of foodborne ... three months and full year ended December 31, ... for the quarter ended December 31, 2014 was ... quarter of 2013 and $1.5 million for the ...
Breaking Biology Technology:World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 3SurePure Completes Verification and Approved for Trading on the OTCQB Marketplace 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 2Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 5Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 7
Cached News: